FLT3 inhibitors as maintenance therapy post allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with FLT3 mutations: A meta‐analysis

BACKGROUND: Acute myeloid leukemia (AML) patients with a Fms‐like tyrosine kinase 3 (FLT3) mutation have a high incidence of relapse despite allogeneic hematopoietic stem cell transplantation (allo‐HSCT) and a subsequent poor prognosis. FLT3 inhibitors (FLT3i) have been suggested to reduce the post‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Fei, Xinhong, Zhang, Shuqin, Gu, Jiangying, Wang, Jingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067110/
https://www.ncbi.nlm.nih.gov/pubmed/36411731
http://dx.doi.org/10.1002/cam4.5480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067110/
https://www.ncbi.nlm.nih.gov/pubmed/36411731
http://dx.doi.org/10.1002/cam4.5480

Ejemplares similares